XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	6,400	6,600	07:00

Realtime

Geld

Brief

Zeit

6,400

6,600

07:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 30.08.2024

Das Instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 30.08.2024 und ex Kapitalmassnahme am 02.09.2024
The instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY is traded cum capital adjustment on 30.08.2024 and ex capital adjustment on 02.09.2024

Das Instrument 5KV GB00BF7J2535 TRIDENT ROY. PLC LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 30.08.2024 und ex Kapitalmassnahme am 02.09.2024
The instrument 5KV GB00BF7J2535 TRIDENT ROY. PLC LS-,01 EQUITY is traded cum capital adjustment on 30.08.2024 and ex capital adjustment on 02.09.2024

Das Instrument S21 SE0011725084 S2MEDICAL AB B EQUITY wird ex Kapitalmassnahme gehandelt am 30.08.2024
The instrument S21 SE0011725084 S2MEDICAL AB B EQUITY is traded ex capital adjustment on 30.08.2024

Das Instrument GPH IL0011313900 GALMED PHARMACEUT.IS 1,80 EQUITY wird ex Kapitalmassnahme gehandelt am 30.08.2024
The instrument GPH IL0011313900 GALMED PHARMACEUT.IS 1,80 EQUITY is traded ex capital adjustment on 30.08.2024

Das Instrument 3YZ NL00150006R6 CTP N.V. EO 1 EQUITY wird cum Kapitalmassnahme gehandelt am 30.08.2024 und ex Kapitalmassnahme am 02.09.2024
The instrument 3YZ NL00150006R6 CTP N.V. EO 1 EQUITY is traded cum capital adjustment on 30.08.2024 and ex capital adjustment on 02.09.2024

Zeit	Aktuelle Nachrichten
15.04.	Awilco LNG ASA - Annual General Meeting
09.04.	Awilco LNG ASA - Annual report 2024
25.02.	Awilco LNG ASA - Fourth quarter 2024 results
17.12.24	AWILCO LNG ASA: Financial calendar
14.11.24	Awilco LNG ASA - Third quarter 2024 results

Zeit

Aktuelle Nachrichten

15.04.

Awilco LNG ASA - Annual General Meeting

09.04.

Awilco LNG ASA - Annual report 2024

25.02.

Awilco LNG ASA - Fourth quarter 2024 results

17.12.24

AWILCO LNG ASA: Financial calendar

14.11.24

Awilco LNG ASA - Third quarter 2024 results

Zeit	Aktuelle Nachrichten
Do	Dividendenbekanntmachungen (24.04.2025)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0127 EUR ALPHA GROUP INTERNATIONAL PLC GB00BF1TM596 0,14 GBP 0,1638 EUR AQ GROUP AB SE0022062196 1... ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 23.04.2025	Das Instrument DGD AU000000DEG6 DE GREY MINING LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 23.04.2025 und ex Kapitalmassnahme am 24.04.2025 The instrument DGD AU000000DEG6 DE GREY MINING LTD.... ► Artikel lesen
Di	CTP N.V. 2025 Annual General Meeting voting results and dividend	Regulatory News: CTP N.V. ('CTP' or the 'Company'), Europe's largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, today announces the voting... ► Artikel lesen
11.04.	CTP N.V. Notice of Q1-2025 Results	Regulatory News: CTP N.V. ('CTP' or the 'Company'), Europe's largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, will announce its Q1-2025... ► Artikel lesen
10.04.	CTP Transforms Zátiší Barracks in Plzen into Thriving Business Destination

Zeit

Aktuelle Nachrichten

Dividendenbekanntmachungen (24.04.2025)

Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0127 EUR ALPHA GROUP INTERNATIONAL PLC GB00BF1TM596 0,14 GBP 0,1638 EUR AQ GROUP AB SE0022062196 1...
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 23.04.2025

Das Instrument DGD AU000000DEG6 DE GREY MINING LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 23.04.2025 und ex Kapitalmassnahme am 24.04.2025 The instrument DGD AU000000DEG6 DE GREY MINING LTD....
► Artikel lesen

CTP N.V. 2025 Annual General Meeting voting results and dividend

Regulatory News: CTP N.V. ('CTP' or the 'Company'), Europe's largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, today announces the voting...
► Artikel lesen

11.04.

CTP N.V. Notice of Q1-2025 Results

Regulatory News: CTP N.V. ('CTP' or the 'Company'), Europe's largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, will announce its Q1-2025...
► Artikel lesen

10.04.

CTP Transforms Zátiší Barracks in Plzen into Thriving Business Destination

Zeit	Aktuelle Nachrichten
17.04.	Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer
15.04.	Galmed Pharmaceuticals Ltd.: Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor	Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological... ► Artikel lesen
10.04.	Galmed Reports Positive Part 1 Results From AM-001 Study Of Aramchol Meglumine
10.04.	Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer
10.04.	Galmed Pharmaceuticals Ltd.: Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor	- AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development... ► Artikel lesen

Zeit

Aktuelle Nachrichten

17.04.

Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer

15.04.

Galmed Pharmaceuticals Ltd.: Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor

Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological...
► Artikel lesen

10.04.

Galmed Reports Positive Part 1 Results From AM-001 Study Of Aramchol Meglumine

10.04.

Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer

10.04.

Galmed Pharmaceuticals Ltd.: Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor

- AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development...
► Artikel lesen

Zeit	Aktuelle Nachrichten
30.08.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 30.08.2024		Das Instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 30.08.2024 und ex Kapitalmassnahme am 02.09.2024 The instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY... ► Artikel lesen

Zeit

Aktuelle Nachrichten

30.08.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 30.08.2024